In silico and in vitro evaluation of two novel oximes (K378 and K727) in comparison to K-27 and pralidoxime against paraoxon-ethyl intoxication

References

• Cadieux CL, Wang H, Zhang Y, Koenig JA, Shih TM, McDonough J, Koh J, Cerasoli D. 2016. Probing the activity of a non-oxime reactivator for acetylcholinesterase inhibited by organophosphorus nerve agents. Chem Biol Interact. 259:133–141.
   PubMed Web of Science ®Google Scholar
• Colović MB, Krstić DZ, Lazarević-Pašti TD, Bondžić AM, Vasić VM. 2013. Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 11:315–335.
   PubMed Web of Science ®Google Scholar
• Davies D, Green A. 1959. The chemotherapy of poisoning by organophosphate anticholinesterases. Br J Ind Med. 16:128–134.
   PubMedGoogle Scholar
• de Almeida JS, Cuya Guizado TR, Guimarães AP, Ramalho TC, Gonçalves AS, de Koning MC, França TC. 2016. Docking and molecular dynamics studies of peripheral site ligand-oximes as reactivators of sarin-inhibited human acetylcholinesterase. J Biomol Struct Dyn. 34:2632–2642.
   PubMed Web of Science ®Google Scholar
• de Koning MC, van Grol M, Noort D. 2011. Peripheral site ligand conjugation to a non-quaternary oxime enhances reactivation of nerve agent-inhibited human acetylcholinesterase. Toxicol Lett. 206:54–59.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V, Feather-Stone RM. 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 7:88–95.
   PubMed Web of Science ®Google Scholar
• Kalasz H, Petroianu G. 2007. Comparison of the ability of oximes to reactivate human RBC cholinesterases inhibited by ethyl and methyl paraoxon. Curr Org Chem. 11:1624–1634.
   Web of Science ®Google Scholar
• Kalisiak J, Ralph EC, Cashman JR. 2012. Nonquaternary reactivators for organophosphate-inhibited cholinesterases. J Med Chem. 55:465–474.
   PubMed Web of Science ®Google Scholar
• Kassa J, Misik J, Hatlapatkova J, Zdarova Karasova J. 2017. A comparison of neuroprotective efficacy of two novel reactivators of acetylcholinesterase called K920 and K923 with the oxime K203 and trimedoxime in tabun-poisoned rats. Toxicol Mech Methods. 27:236–243.
   PubMed Web of Science ®Google Scholar
• Kassa J, Pohanka M, Timperley CM, Bird M, Green AC, Tattersall JE. 2016. Evaluation of the benefit of the bispyridinium compound MB327 for the antidotal treatment of nerve agent-poisoned mice. Toxicol Mech Methods. 26:334–339.
   PubMed Web of Science ®Google Scholar
• Kassa J, Sepsova V, Matouskova L, Horova A, Musilek K. 2015. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice. Toxicol Mech Methods. 25:229–233.
   PubMed Web of Science ®Google Scholar
• Kassa J, Sepsova V, Tumova M, Musilek K, Horova A. 2014. The evaluation of the reactivating and therapeutic efficacy of two novel oximes (K361 and K378) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice. Toxicol Mech Methods. 24:173–178.
   PubMed Web of Science ®Google Scholar
• Kuca K, Musilova L, Palecek J, Cirkva V, Paar M, Musilek K, Hrabinova M, Pohanka M, Karasova JZ, Jun D. 2009. Novel bisquaternary oximes – reactivation of acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon. Molecules. 14:4915–4921.
   PubMed Web of Science ®Google Scholar
• Lorke DE, Hasan MY, Nurulain SM, Sheen R, Kuca K, Petroianu GA. 2007. Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the rat brain: comparison with obidoxime. J Appl Toxicol. 27:482–490.
   PubMed Web of Science ®Google Scholar
• Lorke DE, Kalasz H, Petroianu GA, Tekes K. 2008a. Entry of oximes into the brain: a review. Curr Med Chem. 15:743–753.
   PubMed Web of Science ®Google Scholar
• Lorke DE, Nurulain SM, Hasan MY, Kuca K, Musilek K, Petroianu GA. 2008b. Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from diisopropylfluorophosphate toxicity. J Appl Toxicol. 28:920–928.
   PubMed Web of Science ®Google Scholar
• Lorke DE, Petroianu GA. 2009. Minireview: does in-vitro testing of oximes help predict their in-vivo action after paraoxon exposure? J Appl Toxicol. 29:459–469.
   PubMed Web of Science ®Google Scholar
• McHardy SF, Wang HL, McCowen SV, Valdez MC. 2017. Recent advances in acetylcholinesterase inhibitors and reactivators: an update on the patent literature (2012–2015). Expert Opin Ther Pat. 27:455–476.
   PubMed Web of Science ®Google Scholar
• Mercey G, Verdelet T, Renou J, Kliachyna M, Baati R, Nachon F, Jean L, Renard PY. 2012. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents. Acc Chem Res. 45:756–766.
   PubMed Web of Science ®Google Scholar
• Musilek K, Dolezal M, Gunn-Moore F, Kuca K. 2011. Design, evaluation and structure-activity relationship studies of the AChE reactivators against organophosphorus pesticides. Med Res Rev. 31:548–575.
   PubMed Web of Science ®Google Scholar
• Ordentlich A, Barak D, Kronman C, Flashner Y, Leitner M, Segall Y, Ariel N, Cohen S, Velan B, Shafferman A. 1993. Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. J Biol Chem. 268:17083–17095.
   PubMed Web of Science ®Google Scholar
• Petroianu GA. 2013. The history of pyridinium oximes as nerve gas antidotes: the British contribution. Pharmazie. 68:916–918.
   PubMed Web of Science ®Google Scholar
• Petroianu GA, Lorke DE. 2008. Pyridinium oxime reactivators of cholinesterase inhibited by diisopropyl-fluorophosphate (DFP): predictive value of in-vitro testing for in-vivo efficacy. Mini Rev Med Chem. 8:1328–1342.
   PubMed Web of Science ®Google Scholar
• Petroianu GA, Lorke DE, Hasan MY, Adem A, Sheen R, Nurulain SM, Kalasz H. 2007. Paraoxon has only a minimal effect on pralidoxime brain concentration in rats. J Appl Toxicol. 27:350–357.
   PubMed Web of Science ®Google Scholar
• Puntel GO, de Carvalho NR, Gubert P, Palma AS, Dalla Corte CL, Avila DS, Pereira ME, Carratu VS, Bresolin L, da Rocha JB, et al. 2009. Butane-2,3-dionethiosemicarbazone: an oxime with antioxidant properties. Chem Biol Interact. 177:153–160.
   PubMed Web of Science ®Google Scholar
• Sakurada K, Matsubara K, Shimizu K, Shiono H, Seto Y, Tsuge K, Yoshino M, Sakai I, Mukoyama H, Takatori T. 2003. Pralidoxime iodide (2-pAM) penetrates across the blood-brain barrier. Neurochem Res. 28:1401–1407.
   PubMed Web of Science ®Google Scholar
• Sinko G, Brglez J, Kovarik Z. 2010. Interactions of pyridinium oximes with acetylcholinesterase. Chem Biol Interact. 187:172–176.
   PubMed Web of Science ®Google Scholar
• Sussman JL, Harel M, Frolow F, Oefner C, Goldman A, Toker L, Silman I. 1991. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science. 253:872–879.
   PubMed Web of Science ®Google Scholar
• Swami D, Karade HN, Acharya J, Kumar P. 2016. In vivo protection studies of bis-quaternary 2-(hydroxyimino)-N-(pyridin-3-yl) acetamide derivatives against sarin poisoning in mice. Hum Exp Toxicol. 36:23–32.
   Web of Science ®Google Scholar
• Wilson IB, Ginsburg B. 1955. A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase. Biochim Biophys Acta. 18:168–170.
   PubMed Web of Science ®Google Scholar
• Worek F, Mast U, Kiderlen D, Diepold C, Eyer P. 1999. Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta. 288:73–90.
   PubMed Web of Science ®Google Scholar
• Worek F, Wille T, Koller M, Thiermann H. 2016. Toxicology of organophosphorus compounds in view of an increasing terrorist threat. Arch Toxicol. 90:2131–2145.
   PubMed Web of Science ®Google Scholar